![](https://endpts.com/wp-content/uploads/2023/12/John-Reed-JJ-tile.jpg)
John Reed, J&J’s EVP of innovative medicine
J&J promises 20 new drugs to back pharma growth through end of decade, as John Reed shares his plans
Johnson & Johnson is laying out its drug development ambitions under its new R&D chief, projecting that it will bring in billions of dollars in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.